Barbara Antonioli
Overview
Explore the profile of Barbara Antonioli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marchini A, Ciulla M, Antonioli B, Agnoli A, Bovio U, Visnoviz V, et al.
Front Bioeng Biotechnol
. 2023 Mar;
11:1105157.
PMID: 36911193
Human pancreatic islets transplantation is an experimental therapeutic treatment for Type I Diabetes. Limited islets lifespan in culture remains the main drawback, due to the absence of native extracellular matrix...
2.
Antonioli B, Tosca M, Pintaudi B, Guidoni F, Galuzzi M, Pelizzoni C, et al.
Burns
. 2022 Jun;
49(4):797-805.
PMID: 35725930
Skin allografts represent a milestone in burn patient treatment. However, skin procurement is still burdened by high rates of contamination, and validation procedures have not yet been standardized. In addition,...
3.
DAddio F, Maestroni A, Assi E, Ben Nasr M, Amabile G, Usuelli V, et al.
Nat Commun
. 2022 Feb;
13(1):684.
PMID: 35115561
Loss of pancreatic beta cells is a central feature of type 1 (T1D) and type 2 (T2D) diabetes, but a therapeutic strategy to preserve beta cell mass remains to be...
4.
Nano R, Kerr-Conte J, Scholz H, Engelse M, Karlsson M, Saudek F, et al.
Transplantation
. 2019 Aug;
104(1):190-196.
PMID: 31365472
Background: Europe is currently the most active region in the field of pancreatic islet transplantation, and many of the leading groups are actually achieving similar good outcomes. Further collaborative advances...
5.
Galuzzi M, Perteghella S, Antonioli B, Tosca M, Bari E, Tripodo G, et al.
Polymers (Basel)
. 2019 Apr;
10(7).
PMID: 30960663
(1) Objective: to obtain a reproducible, robust, well-defined, and cost-affordable in vitro model of human cartilage degeneration, suitable for drug screening; (2) Methods: we proposed 3D models of engineered cartilage,...
6.
Bertuzzi F, De Carlis L, Marazzi M, Rampoldi A, Bonomo M, Antonioli B, et al.
Cell Transplant
. 2018 Jun;
27(5):840-846.
PMID: 29871516
Islet transplantation has been reported to restore normoglycemia and the overall metabolic control in type 1 diabetes mellitus (DM). In the most experienced centers, islet transplantation clinical outcome is similar...
7.
Perteghella S, Vigani B, Mastracci L, Grillo F, Antonioli B, Galuzzi M, et al.
Macromol Biosci
. 2017 Jul;
17(9).
PMID: 28691373
The aim of this study is to assess whether stromal vascular fraction (SVF)-soaked silk fibroin nonwoven mats (silk-SVF) can preserve the functionality of encapsulated pancreatic endocrine cells (alginate-PECs) after transplantation...
8.
Bertuzzi F, Marazzi M, De Carlis L, Rampoldi A, Bonomo M, Antonioli B, et al.
Transplantation
. 2016 Aug;
100(11):e117-e118.
PMID: 27517727
No abstract available.
9.
Bertuzzi F, Antonioli B, Tosca M, Galuzzi M, Bonomo M, Marazzi M, et al.
Endocr Dev
. 2015 Dec;
30:14-22.
PMID: 26682915
The first islet transplantation in diabetes mellitus was performed more than 20 years ago. Since then, clinical results have progressively improved. Nowadays, islet transplantation can be considered a real therapeutic...
10.
Tripodo G, Chlapanidas T, Perteghella S, Vigani B, Mandracchia D, Trapani A, et al.
Colloids Surf B Biointerfaces
. 2014 Dec;
125:300-8.
PMID: 25524221
This work reports on the formation of a carrier-in-carrier device for the systemic delivery and targeting of hydrophobic drugs mediated by micelle-loaded mesenchymal stromal cells (MSCs) (carrier-in-carrier) to be administered...